Whitehawk Therapeutics (WHWK) Long-Term Debt Issuances (2010 - 2017)

Whitehawk Therapeutics (WHWK) has reported Long-Term Debt Issuances for 6 consecutive years, with $297354.0 the latest figure, recorded in Q1 2017.

• In Q1 2017, Long-Term Debt Issuances changed N/A year-over-year to $297354.0; the TTM figure through Dec 2017 stood at $297354.0 (down 96.29% YoY), while the FY2017 annual figure was $297354.0, down 97.63% from the prior year.
• Long-Term Debt Issuances retreated to $297354.0 in Q1 2017 per WHWK's latest filing, from $3.5 million in the prior quarter.
• Across five years, Long-Term Debt Issuances topped out at $4.5 million in Q3 2016 and bottomed at $15000.0 in Q4 2015.
• Historically, Long-Term Debt Issuances has averaged $1.4 million across 4 years, with a median of $161177.0 in 2013.
• On a YoY basis, Long-Term Debt Issuances climbed as much as 23027.61% in 2016 and fell as far as 23027.61% in 2016.
• Whitehawk Therapeutics' Long-Term Debt Issuances stood at $25000.0 in 2013, then sank by 40.0% to $15000.0 in 2015, then soared by 23027.61% to $3.5 million in 2016, then tumbled by 91.43% to $297354.0 in 2017.
• Business Quant data shows WHWK's Long-Term Debt Issuances at $297354.0 in Q1 2017, $3.5 million in Q4 2016, and $4.5 million in Q3 2016.